Clinical Trial Update: Evaluating the Use of Thymoglobulin, Sirolimus, and Donor Bone Marrow With Kidney Transplantation Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating thymoglobulin, sirolimus, and donor bone marrow in kidney transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Donor bone marrow
• Sirolimus (Sirolimus)
• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Kidney Transplantation | Phase 2 | Status: COMPLETED